| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.14e-10 | 49 | 38 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TMC8 LRRC8C ANO9 GRIK2 ABCA1 GRIK3 ABCA4 TMC1 SLC9C2 ABCA13 ABCA7 PANX3 ABCC6 ABCC10 SLC52A3 | 1.46e-09 | 1180 | 38 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | TMC8 LRRC8C ANO9 GRIK2 ABCA1 GRIK3 ABCA4 TMC1 SLC9C2 ABCA13 ABCA7 PANX3 ABCC6 ABCC10 SLC52A3 | 4.90e-09 | 1289 | 38 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.51e-08 | 109 | 38 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.00e-06 | 178 | 38 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.61e-06 | 51 | 38 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor activity | 3.53e-06 | 2 | 38 | 2 | GO:0034188 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 1.06e-05 | 3 | 38 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.17e-05 | 74 | 38 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.80e-05 | 27 | 38 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.02e-05 | 28 | 38 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.21e-05 | 459 | 38 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.82e-05 | 477 | 38 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GRIK2 ABCA1 GRIK3 DRD4 CD300LD LTK HTR2A GRM4 ABCA7 GPR157 OR52L1 | 2.90e-05 | 1353 | 38 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.34e-05 | 196 | 38 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.84e-05 | 100 | 38 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | channel activity | 5.19e-05 | 525 | 38 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.25e-05 | 526 | 38 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 5.26e-05 | 6 | 38 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.39e-05 | 758 | 38 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 9.80e-05 | 8 | 38 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 9.80e-05 | 8 | 38 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.01e-04 | 793 | 38 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.26e-04 | 9 | 38 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.26e-04 | 9 | 38 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.26e-04 | 9 | 38 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.57e-04 | 10 | 38 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.70e-04 | 441 | 38 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | serotonin binding | 2.71e-04 | 13 | 38 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.65e-04 | 15 | 38 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.91e-04 | 75 | 38 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.05e-04 | 334 | 38 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | floppase activity | 4.16e-04 | 16 | 38 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.71e-04 | 17 | 38 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 5.29e-04 | 18 | 38 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 5.29e-04 | 18 | 38 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 6.56e-04 | 20 | 38 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | amine binding | 7.24e-04 | 21 | 38 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 7.95e-04 | 22 | 38 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.48e-04 | 24 | 38 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 9.84e-04 | 614 | 38 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.79e-03 | 465 | 38 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.90e-03 | 34 | 38 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 2.13e-03 | 36 | 38 | 2 | GO:0030296 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 2.13e-03 | 36 | 38 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 2.76e-03 | 41 | 38 | 2 | GO:0008227 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 2.84e-03 | 149 | 38 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 3.20e-03 | 775 | 38 | 6 | GO:0017111 | |
| GeneOntologyMolecularFunction | kinase activator activity | 3.41e-03 | 159 | 38 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.91e-03 | 167 | 38 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.98e-03 | 343 | 38 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.18e-03 | 171 | 38 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.18e-03 | 171 | 38 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.40e-03 | 52 | 38 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 4.72e-03 | 839 | 38 | 6 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 4.75e-03 | 840 | 38 | 6 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.75e-03 | 840 | 38 | 6 | GO:0016818 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.27e-03 | 57 | 38 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.82e-03 | 60 | 38 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.85e-03 | 193 | 38 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 6.01e-03 | 61 | 38 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 6.08e-03 | 884 | 38 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.19e-03 | 197 | 38 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 6.40e-03 | 627 | 38 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.80e-03 | 65 | 38 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.80e-03 | 65 | 38 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 8.11e-03 | 664 | 38 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 9.43e-03 | 77 | 38 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.14e-02 | 85 | 38 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.14e-02 | 85 | 38 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.17e-02 | 86 | 38 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 1.30e-02 | 259 | 38 | 3 | GO:0019887 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TMC8 LRRC8C ANO9 GRIK2 GRIK3 DRD4 TMC1 HTR2A SLC9C2 PANX3 ABCC6 ABCC10 | 4.29e-07 | 1115 | 38 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 4.80e-07 | 162 | 38 | 6 | GO:0015748 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 1.63e-06 | 13 | 38 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 3.12e-06 | 55 | 38 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid transport | 3.18e-06 | 506 | 38 | 8 | GO:0006869 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 3.55e-06 | 358 | 38 | 7 | GO:0015850 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TMC8 LRRC8C ANO9 GRIK2 GRIK3 DRD4 TMC1 HTR2A SLC9C2 PANX3 ABCC6 ABCC10 | 3.88e-06 | 1374 | 38 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid translocation | 4.43e-06 | 60 | 38 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 6.12e-06 | 65 | 38 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 6.91e-06 | 67 | 38 | 4 | GO:0099171 | |
| GeneOntologyBiologicalProcess | lipid localization | 7.14e-06 | 565 | 38 | 8 | GO:0010876 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.40e-05 | 80 | 38 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.44e-05 | 92 | 38 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | learning | 4.17e-05 | 212 | 38 | 5 | GO:0007612 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 4.25e-05 | 106 | 38 | 4 | GO:0015914 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 5.44e-05 | 40 | 38 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 5.44e-05 | 40 | 38 | 3 | GO:0032376 | |
| GeneOntologyBiologicalProcess | apolipoprotein A-I-mediated signaling pathway | 6.90e-05 | 7 | 38 | 2 | GO:0038027 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 6.90e-05 | 7 | 38 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 9.99e-05 | 132 | 38 | 4 | GO:0035249 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 1.18e-04 | 9 | 38 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.71e-04 | 286 | 38 | 5 | GO:0007188 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.75e-04 | 59 | 38 | 3 | GO:0007215 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.77e-04 | 153 | 38 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 2.55e-04 | 13 | 38 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.82e-04 | 173 | 38 | 4 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.95e-04 | 175 | 38 | 4 | GO:0009582 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 3.28e-04 | 73 | 38 | 3 | GO:0071715 | |
| GeneOntologyBiologicalProcess | phospholipid efflux | 3.42e-04 | 15 | 38 | 2 | GO:0033700 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.50e-04 | 183 | 38 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | memory | 3.50e-04 | 183 | 38 | 4 | GO:0007613 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 3.90e-04 | 16 | 38 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 4.79e-04 | 83 | 38 | 3 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 4.79e-04 | 83 | 38 | 3 | GO:0032371 | |
| GeneOntologyBiologicalProcess | ceramide transport | 4.96e-04 | 18 | 38 | 2 | GO:0035627 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5.31e-04 | 86 | 38 | 3 | GO:0007193 | |
| GeneOntologyBiologicalProcess | learning or memory | 5.79e-04 | 373 | 38 | 5 | GO:0007611 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 7.32e-04 | 96 | 38 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 7.46e-04 | 22 | 38 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 8.16e-04 | 23 | 38 | 2 | GO:0098664 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 8.73e-04 | 102 | 38 | 3 | GO:0032370 | |
| GeneOntologyBiologicalProcess | behavioral response to cocaine | 8.89e-04 | 24 | 38 | 2 | GO:0048148 | |
| GeneOntologyBiologicalProcess | cognition | 1.02e-03 | 423 | 38 | 5 | GO:0050890 | |
| GeneOntologyBiologicalProcess | behavior | 1.07e-03 | 891 | 38 | 7 | GO:0007610 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.13e-03 | 27 | 38 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.13e-03 | 27 | 38 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.13e-03 | 27 | 38 | 2 | GO:0035235 | |
| GeneOntologyBiologicalProcess | signal release | 1.14e-03 | 653 | 38 | 6 | GO:0023061 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.24e-03 | 663 | 38 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.25e-03 | 664 | 38 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.27e-03 | 116 | 38 | 3 | GO:0015844 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 1.30e-03 | 29 | 38 | 2 | GO:0034377 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 1.39e-03 | 30 | 38 | 2 | GO:0050961 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.57e-03 | 125 | 38 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.58e-03 | 32 | 38 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 1.68e-03 | 33 | 38 | 2 | GO:0016048 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 1.68e-03 | 33 | 38 | 2 | GO:0065005 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.69e-03 | 705 | 38 | 6 | GO:0055080 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 1.72e-03 | 129 | 38 | 3 | GO:1905954 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.85e-03 | 717 | 38 | 6 | GO:0050801 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 1.92e-03 | 134 | 38 | 3 | GO:0030301 | |
| GeneOntologyBiologicalProcess | amine transport | 2.04e-03 | 137 | 38 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | sterol transport | 2.13e-03 | 139 | 38 | 3 | GO:0015918 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 2.23e-03 | 38 | 38 | 2 | GO:0050951 | |
| GeneOntologyBiologicalProcess | organic anion transport | 2.42e-03 | 515 | 38 | 5 | GO:0015711 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 2.47e-03 | 40 | 38 | 2 | GO:1990806 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 2.47e-03 | 40 | 38 | 2 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 2.72e-03 | 42 | 38 | 2 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 2.98e-03 | 44 | 38 | 2 | GO:0015865 | |
| GeneOntologyBiologicalProcess | sensory perception | 3.08e-03 | 1072 | 38 | 7 | GO:0007600 | |
| GeneOntologyBiologicalProcess | import into cell | 3.11e-03 | 1074 | 38 | 7 | GO:0098657 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SGPP1 TMC8 LRRC8C ABCA1 SSR2 PTGS1 GDPD3 PANX3 ABCC6 GGCX PIGM | 1.24e-05 | 1293 | 38 | 11 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SGPP1 TMC8 LRRC8C ABCA1 SSR2 PTGS1 GDPD3 PANX3 ABCC6 GGCX PIGM | 1.29e-05 | 1299 | 38 | 11 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SGPP1 TMC8 LRRC8C ABCA1 SSR2 PTGS1 GDPD3 PANX3 ABCC6 GGCX PIGM | 1.58e-05 | 1327 | 38 | 11 | GO:0042175 |
| GeneOntologyCellularComponent | terminal bouton | 2.74e-05 | 96 | 38 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 4.80e-05 | 6 | 38 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.38e-04 | 277 | 38 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | axon terminus | 5.59e-04 | 210 | 38 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.25e-04 | 233 | 38 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | presynapse | 9.58e-04 | 886 | 38 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.07e-03 | 111 | 38 | 3 | GO:0001750 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.27e-03 | 29 | 38 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.05e-03 | 139 | 38 | 3 | GO:0097733 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.13e-03 | 141 | 38 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 2.29e-03 | 39 | 38 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.69e-03 | 153 | 38 | 3 | GO:0097731 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 3.03e-03 | 45 | 38 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.32e-03 | 817 | 38 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 3.73e-03 | 50 | 38 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.89e-03 | 583 | 38 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | dendrite | 4.22e-03 | 858 | 38 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.26e-03 | 860 | 38 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | axon | 5.06e-03 | 891 | 38 | 6 | GO:0030424 | |
| GeneOntologyCellularComponent | non-motile cilium | 5.38e-03 | 196 | 38 | 3 | GO:0097730 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.09e-03 | 405 | 38 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | distal axon | 7.81e-03 | 435 | 38 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | dendritic shaft | 8.00e-03 | 74 | 38 | 2 | GO:0043198 | |
| HumanPheno | Yellow papule | 4.20e-05 | 4 | 14 | 2 | HP:0025507 | |
| HumanPheno | Retinal peau d'orange | 4.20e-05 | 4 | 14 | 2 | HP:0033027 | |
| MousePheno | decreased paired-pulse facilitation | 2.66e-05 | 25 | 33 | 3 | MP:0002920 | |
| Domain | ABC_TRANSPORTER_2 | 5.41e-10 | 48 | 38 | 6 | PS50893 | |
| Domain | ABC_tran | 5.41e-10 | 48 | 38 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.15e-10 | 49 | 38 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 6.98e-10 | 50 | 38 | 6 | IPR003439 | |
| Domain | ABC_A | 7.13e-09 | 12 | 38 | 4 | IPR026082 | |
| Domain | ABC_transporter_CS | 2.14e-08 | 42 | 38 | 5 | IPR017871 | |
| Domain | AAA+_ATPase | 4.26e-07 | 144 | 38 | 6 | IPR003593 | |
| Domain | AAA | 4.26e-07 | 144 | 38 | 6 | SM00382 | |
| Domain | ANF_receptor | 5.76e-05 | 37 | 38 | 3 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 5.76e-05 | 37 | 38 | 3 | IPR001828 | |
| Domain | Liprin | 6.02e-05 | 6 | 38 | 2 | IPR029515 | |
| Domain | Peripla_BP_I | 6.75e-05 | 39 | 38 | 3 | IPR028082 | |
| Domain | TMC | 1.12e-04 | 8 | 38 | 2 | PF07810 | |
| Domain | TMC | 1.12e-04 | 8 | 38 | 2 | IPR012496 | |
| Domain | Iontro_rcpt | 6.04e-04 | 18 | 38 | 2 | IPR001320 | |
| Domain | Lig_chan | 6.04e-04 | 18 | 38 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 6.04e-04 | 18 | 38 | 2 | PF10613 | |
| Domain | PBPe | 6.04e-04 | 18 | 38 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 6.04e-04 | 18 | 38 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 6.04e-04 | 18 | 38 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.04e-04 | 18 | 38 | 2 | SM00918 | |
| Domain | ABC_membrane | 1.08e-03 | 24 | 38 | 2 | PF00664 | |
| Domain | ABC_TM1F | 1.47e-03 | 28 | 38 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 1.47e-03 | 28 | 38 | 2 | IPR011527 | |
| Domain | SAM_2 | 3.45e-03 | 43 | 38 | 2 | PF07647 | |
| Domain | - | 3.69e-03 | 746 | 38 | 6 | 3.40.50.300 | |
| Domain | - | 4.29e-03 | 48 | 38 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 4.83e-03 | 51 | 38 | 2 | IPR014710 | |
| Domain | P-loop_NTPase | 6.85e-03 | 848 | 38 | 6 | IPR027417 | |
| Domain | SAM_1 | 8.44e-03 | 68 | 38 | 2 | PF00536 | |
| Domain | SAM | 1.38e-02 | 88 | 38 | 2 | SM00454 | |
| Domain | SAM_DOMAIN | 1.60e-02 | 95 | 38 | 2 | PS50105 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 6.75e-10 | 44 | 33 | 6 | M11911 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 8.01e-05 | 99 | 33 | 4 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 9.34e-05 | 103 | 33 | 4 | M758 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.30e-04 | 736 | 33 | 8 | M27287 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.36e-04 | 10 | 33 | 2 | M10272 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 3.05e-04 | 140 | 33 | 4 | M42572 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 3.46e-04 | 12 | 33 | 2 | MM15142 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.93e-04 | 272 | 33 | 5 | M13380 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 7.07e-04 | 17 | 33 | 2 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 7.07e-04 | 17 | 33 | 2 | MM14907 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 7.94e-04 | 18 | 33 | 2 | M27043 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 7.94e-04 | 18 | 33 | 2 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 7.94e-04 | 18 | 33 | 2 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 7.94e-04 | 18 | 33 | 2 | MM14703 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.46e-04 | 681 | 33 | 7 | MM14985 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 9.83e-04 | 20 | 33 | 2 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 9.83e-04 | 20 | 33 | 2 | MM14991 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.30e-03 | 23 | 33 | 2 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.30e-03 | 23 | 33 | 2 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.42e-03 | 24 | 33 | 2 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.42e-03 | 24 | 33 | 2 | M630 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.42e-03 | 211 | 33 | 4 | MM14502 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.22e-03 | 30 | 33 | 2 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.52e-03 | 32 | 33 | 2 | MM15143 | |
| Pathway | WP_MONOAMINE_GPCRS | 2.68e-03 | 33 | 33 | 2 | M39585 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.48e-03 | 270 | 33 | 4 | M15514 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 24097981 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 3.42e-07 | 13 | 38 | 3 | 20859245 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 14570867 | ||
| Pubmed | ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum. | 1.16e-06 | 2 | 38 | 2 | 12673275 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15094479 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26749169 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 29221470 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17620617 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 28373057 | ||
| Pubmed | Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes. | 1.16e-06 | 2 | 38 | 2 | 18800149 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25665932 | ||
| Pubmed | Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. | 1.16e-06 | 2 | 38 | 2 | 15930518 | |
| Pubmed | Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity. | 1.16e-06 | 2 | 38 | 2 | 28103253 | |
| Pubmed | Atypical functional properties of GluK3-containing kainate receptors. | 1.16e-06 | 2 | 38 | 2 | 20007474 | |
| Pubmed | Expression of the Abca-subfamily of genes in Abcc6-/- mice--upregulation of Abca4. | 1.16e-06 | 2 | 38 | 2 | 21435020 | |
| Pubmed | 1.83e-06 | 22 | 38 | 3 | 8894702 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 2.10e-06 | 23 | 38 | 3 | 10708515 | |
| Pubmed | 2.16e-06 | 193 | 38 | 5 | 19343046 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 2.40e-06 | 24 | 38 | 3 | 35746896 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 31513786 | ||
| Pubmed | ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. | 3.48e-06 | 3 | 38 | 2 | 18793613 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22403608 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 32567721 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 3.48e-06 | 3 | 38 | 2 | 15805114 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 27815333 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15520449 | ||
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 3.48e-06 | 3 | 38 | 2 | 9880586 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 19721717 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 15513934 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 20495215 | ||
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 6.96e-06 | 4 | 38 | 2 | 12954862 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 6.96e-06 | 4 | 38 | 2 | 30241548 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 15383158 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 19369569 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 16281377 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 1.16e-05 | 5 | 38 | 2 | 23076118 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 16272956 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 11992560 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 26448475 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 1.16e-05 | 5 | 38 | 2 | 18793656 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 18063936 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 28228252 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 12223554 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 9466455 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 19013515 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 18358623 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 17142808 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 1.16e-05 | 5 | 38 | 2 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 1.16e-05 | 5 | 38 | 2 | 29058671 | |
| Pubmed | [Associations between six functional genes and schizophrenia]. | 1.16e-05 | 5 | 38 | 2 | 12579508 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 12650952 | ||
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 1.74e-05 | 6 | 38 | 2 | 21618221 | |
| Pubmed | Influence of dopaminergic and serotoninergic genes on working memory in healthy subjects. | 1.74e-05 | 6 | 38 | 2 | 20407490 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 12111378 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.74e-05 | 6 | 38 | 2 | 28714086 | |
| Pubmed | The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. | 1.74e-05 | 6 | 38 | 2 | 11943148 | |
| Pubmed | Correlates of response to Olanzapine in a North Indian Schizophrenia sample. | 2.43e-05 | 7 | 38 | 2 | 19000940 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 27460988 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 17428973 | ||
| Pubmed | [The molecular-genetic study of juvenile endogenous attack-like psychoses]. | 2.43e-05 | 7 | 38 | 2 | 18379473 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 2.43e-05 | 7 | 38 | 2 | 9016303 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 2.43e-05 | 7 | 38 | 2 | 9651535 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 1310861 | ||
| Pubmed | Plasticity genes do not modify associations between physical activity and depressive symptoms. | 3.24e-05 | 8 | 38 | 2 | 23088179 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 12812529 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 12906855 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 15802388 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 24293640 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 3.24e-05 | 8 | 38 | 2 | 8163463 | |
| Pubmed | 3.75e-05 | 59 | 38 | 3 | 20855565 | ||
| Pubmed | Correlation of a set of gene variants, life events and personality features on adult ADHD severity. | 4.16e-05 | 9 | 38 | 2 | 20006992 | |
| Pubmed | Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. | 4.16e-05 | 9 | 38 | 2 | 11162594 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 4.16e-05 | 9 | 38 | 2 | 9051806 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 12923177 | ||
| Pubmed | Support for association between ADHD and two candidate genes: NET1 and DRD1. | 6.35e-05 | 11 | 38 | 2 | 15717291 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 7.62e-05 | 12 | 38 | 2 | 9624153 | |
| Pubmed | 8.99e-05 | 79 | 38 | 3 | 19056482 | ||
| Pubmed | 9.68e-05 | 81 | 38 | 3 | 22723691 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 18937842 | ||
| Pubmed | Excitatory glutamate is essential for development and maintenance of the piloneural mechanoreceptor. | 1.21e-04 | 15 | 38 | 2 | 22241839 | |
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 1.38e-04 | 16 | 38 | 2 | 35307651 | |
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 19506906 | ||
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 18270970 | ||
| Pubmed | 2.65e-04 | 22 | 38 | 2 | 21348951 | ||
| Pubmed | CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP. | 2.65e-04 | 22 | 38 | 2 | 34187934 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.84e-04 | 1201 | 38 | 7 | 35696571 | |
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 8464923 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 2.95e-04 | 118 | 38 | 3 | 19156168 | |
| Pubmed | 3.16e-04 | 24 | 38 | 2 | 21821099 | ||
| Pubmed | 3.18e-04 | 300 | 38 | 4 | 19086053 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 3.74e-04 | 128 | 38 | 3 | 19058789 | |
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 19352218 | ||
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 4.96e-04 | 30 | 38 | 2 | 16186258 | |
| Pubmed | 5.30e-04 | 31 | 38 | 2 | 15217342 | ||
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 7.28e-04 | 374 | 38 | 4 | 19625176 | |
| Pubmed | 7.80e-04 | 381 | 38 | 4 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 7.87e-04 | 382 | 38 | 4 | 19170196 | |
| Cytoband | 11p15.5 | 4.33e-03 | 118 | 38 | 2 | 11p15.5 | |
| GeneFamily | ATP binding cassette subfamily A | 6.99e-09 | 14 | 31 | 4 | 805 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 2.84e-05 | 5 | 31 | 2 | 1199 | |
| GeneFamily | Transmembrane channel likes | 7.92e-05 | 8 | 31 | 2 | 1135 | |
| GeneFamily | ATP binding cassette subfamily C | 2.19e-04 | 13 | 31 | 2 | 807 | |
| GeneFamily | Sterile alpha motif domain containing | 9.94e-03 | 88 | 31 | 2 | 760 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 4.68e-05 | 457 | 38 | 6 | M1613 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 5.46e-05 | 470 | 38 | 6 | MM1053 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 1.44e-04 | 184 | 38 | 4 | M6696 | |
| Coexpression | VEGF_A_UP.V1_UP | 1.80e-04 | 195 | 38 | 4 | M2676 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 1.87e-04 | 197 | 38 | 4 | M12824 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_DN | 1.91e-04 | 198 | 38 | 4 | M4426 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 1.94e-04 | 199 | 38 | 4 | M7420 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP | 1.98e-04 | 200 | 38 | 4 | M7206 | |
| Coexpression | GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN | 1.98e-04 | 200 | 38 | 4 | M4439 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.98e-04 | 200 | 38 | 4 | M6620 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 1.98e-04 | 200 | 38 | 4 | M3491 | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.20e-05 | 166 | 38 | 4 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 170 | 38 | 4 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 170 | 38 | 4 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.38e-05 | 172 | 38 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 180 | 38 | 4 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 185 | 38 | 4 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 185 | 38 | 4 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 185 | 38 | 4 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.87e-05 | 186 | 38 | 4 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.87e-05 | 186 | 38 | 4 | 79aedd5aed72509a4925e9f6cb43bc0c798c86f5 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.87e-05 | 186 | 38 | 4 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | Mild_COVID-19-Myeloid-pDC|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.91e-05 | 187 | 38 | 4 | 99c3c4a7b9179dce7982dc6516d561c952abc80e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 191 | 38 | 4 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 2.08e-05 | 191 | 38 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 194 | 38 | 4 | 87604c93d20f9171e0a1279bdb6ad73fe5fed356 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | e60deb009238702110c3b0948778802df215ad74 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | c1345893e6947ccf9b41282d0e4428dbfb8bcc27 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | b652bc73adfdeccbdcd74497ab6e2085e5c95e88 | |
| ToppCell | proximal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | 51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | ccd0edd483728279fe15d64be3a39e8636bf2eeb | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | cbe3e107ac16c17687d73ebb04c39d51aba1fa98 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 94 | 38 | 3 | 9d1dfd534871da30bc25a42e36bed9826f6127d8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 94 | 38 | 3 | 858dda192747e71533736247bc9e135f763a8860 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 94 | 38 | 3 | 901c4908d27a06c81853a02042cd331549e0e27d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 128 | 38 | 3 | fbdefc29e087d36b17904c3f69302927157492a0 | |
| ToppCell | Control-dn_T|Control / Disease condition and Cell class | 1.76e-04 | 128 | 38 | 3 | e492684b2eafc6c91d2e7d7b9f54defb6642069e | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.85e-04 | 130 | 38 | 3 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_Naive|URO / Disease, Lineage and Cell Type | 2.02e-04 | 134 | 38 | 3 | 142b7db0c2b686c8f2704ff7bcd9b44dfcb07403 | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 142 | 38 | 3 | a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 142 | 38 | 3 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 142 | 38 | 3 | 70f8c1be134835e0d21e6d426b7122f0f5d3d3e5 | |
| ToppCell | Control-Hematopoietic_Mast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 142 | 38 | 3 | db9b7acbab730ae391a362f1ca8177507e52250d | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.50e-04 | 144 | 38 | 3 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 145 | 38 | 3 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-04 | 149 | 38 | 3 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 151 | 38 | 3 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 156 | 38 | 3 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.16e-04 | 156 | 38 | 3 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-04 | 159 | 38 | 3 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.34e-04 | 159 | 38 | 3 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-04 | 159 | 38 | 3 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.34e-04 | 159 | 38 | 3 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.40e-04 | 160 | 38 | 3 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.46e-04 | 161 | 38 | 3 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 3.46e-04 | 161 | 38 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 3.46e-04 | 161 | 38 | 3 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 162 | 38 | 3 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.59e-04 | 163 | 38 | 3 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.59e-04 | 163 | 38 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 3.65e-04 | 164 | 38 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-04 | 166 | 38 | 3 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-04 | 166 | 38 | 3 | 2e4cb4056e6b0c43290a5588ff525f5f05b8beee | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-04 | 166 | 38 | 3 | eb8d972326a734549675307e411fc795af66da70 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-04 | 167 | 38 | 3 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 167 | 38 | 3 | cfcd72292c733cdb18c92fdb61b68f6806d22c8c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-04 | 167 | 38 | 3 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.85e-04 | 167 | 38 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 167 | 38 | 3 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 3.92e-04 | 168 | 38 | 3 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.92e-04 | 168 | 38 | 3 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.92e-04 | 168 | 38 | 3 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-04 | 169 | 38 | 3 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 170 | 38 | 3 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 170 | 38 | 3 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 170 | 38 | 3 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 171 | 38 | 3 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-04 | 171 | 38 | 3 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 171 | 38 | 3 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | 13d7117f92a92d77d6b4335ed800c585dc8b4511 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | 3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 4.20e-04 | 172 | 38 | 3 | deda14ba1e760dd46a5e129683d415436e74deb6 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-04 | 172 | 38 | 3 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | a3d431aed12c1192e8dca1dc85b8340fb7354f8d | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 4.20e-04 | 172 | 38 | 3 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | 028a5441242b2cc760cafc1822120180619c63ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | 9fc70b1a143a8ec910336c23b761d908bb6aecb2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 4.34e-04 | 174 | 38 | 3 | 8273de40552d1cca1a8fe3647fd5e4cb4bb70f99 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-04 | 174 | 38 | 3 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-04 | 174 | 38 | 3 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-04 | 174 | 38 | 3 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-04 | 175 | 38 | 3 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.41e-04 | 175 | 38 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-04 | 175 | 38 | 3 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 175 | 38 | 3 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 175 | 38 | 3 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-04 | 176 | 38 | 3 | adb679e69c0c17f0caee4c141bac55d03c963012 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-04 | 176 | 38 | 3 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 176 | 38 | 3 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-04 | 176 | 38 | 3 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 4.49e-04 | 176 | 38 | 3 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 176 | 38 | 3 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-04 | 177 | 38 | 3 | ab92ffc9624850a50c88e6b8f3a517ff2251ff15 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.56e-04 | 177 | 38 | 3 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-04 | 177 | 38 | 3 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 178 | 38 | 3 | b7d1d8f76c1c2467b1a39a9b4150ed4a47144a15 | |
| Computational | Vesicular transport / synapse genes. | 1.71e-05 | 82 | 21 | 4 | MODULE_274 | |
| Drug | 3-isoreserpine | 8.01e-10 | 190 | 38 | 8 | CID000005052 | |
| Drug | LY354740 | 1.56e-06 | 51 | 38 | 4 | CID000114827 | |
| Drug | docetaxel | 2.71e-06 | 133 | 38 | 5 | ctd:C067311 | |
| Drug | glibenclamide | 2.86e-06 | 382 | 38 | 7 | CID000003488 | |
| Drug | L-Glutamic Acid | 4.97e-06 | 68 | 38 | 4 | DB00142 | |
| Drug | AC1L1TSE | 6.25e-06 | 72 | 38 | 4 | CID000060719 | |
| Drug | verapamil | 1.45e-05 | 490 | 38 | 7 | CID000002520 | |
| Drug | hexachlorophene | 1.52e-05 | 90 | 38 | 4 | CID000003598 | |
| Drug | CPPG | 2.48e-05 | 34 | 38 | 3 | CID000002878 | |
| Drug | Remoxipride | 2.70e-05 | 5 | 38 | 2 | DB00409 | |
| Drug | moperone | 2.70e-05 | 5 | 38 | 2 | CID000004249 | |
| Drug | 7-fluoro-2-oxo-4-(2-(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1-yl)ethyl)-1,2-dihydroquinoline-1-acetamide | 2.70e-05 | 5 | 38 | 2 | ctd:C416534 | |
| Drug | tefludazine | 2.70e-05 | 5 | 38 | 2 | CID000071240 | |
| Drug | L-BMAA | 3.48e-05 | 38 | 38 | 3 | CID000028558 | |
| Drug | DETC-MeSO | 3.76e-05 | 39 | 38 | 3 | CID003035711 | |
| Drug | haloperidol | 4.47e-05 | 394 | 38 | 6 | CID000003559 | |
| Drug | LY341495 | 5.05e-05 | 43 | 38 | 3 | CID006324636 | |
| Drug | Joro spider toxin | 5.05e-05 | 43 | 38 | 3 | CID000119582 | |
| Drug | 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine | 5.67e-05 | 7 | 38 | 2 | ctd:C409874 | |
| Drug | tetradotoxin | 7.07e-05 | 428 | 38 | 6 | CID000020382 | |
| Drug | L-745,870 | 7.55e-05 | 8 | 38 | 2 | CID005311200 | |
| Drug | AC1L5523 | 7.55e-05 | 8 | 38 | 2 | CID000170154 | |
| Drug | NRA 0045 | 7.55e-05 | 8 | 38 | 2 | ctd:C106996 | |
| Drug | clozapine | 8.83e-05 | 274 | 38 | 5 | CID000002818 | |
| Drug | AC1L1EKQ | 8.96e-05 | 52 | 38 | 3 | CID000002834 | |
| Drug | LY339434 | 9.69e-05 | 9 | 38 | 2 | CID006324635 | |
| Drug | NIASP | 9.69e-05 | 9 | 38 | 2 | CID006439184 | |
| Drug | BIMT 17 BS | 1.21e-04 | 10 | 38 | 2 | CID006918248 | |
| Drug | tenilapine | 1.21e-04 | 10 | 38 | 2 | CID006450478 | |
| Drug | GYKI 52466 | 1.24e-04 | 58 | 38 | 3 | CID000003538 | |
| Drug | NNC 112 | 1.48e-04 | 11 | 38 | 2 | CID000130424 | |
| Drug | N-methylspiperone | 1.48e-04 | 11 | 38 | 2 | CID000119146 | |
| Drug | octoclothepin | 1.77e-04 | 12 | 38 | 2 | CID000001238 | |
| Drug | Uh 232 | 1.77e-04 | 12 | 38 | 2 | CID000123696 | |
| Drug | benperidol | 1.77e-04 | 12 | 38 | 2 | CID000016363 | |
| Drug | azulene | 1.77e-04 | 12 | 38 | 2 | CID000009231 | |
| Drug | AC1NSKBB | 2.09e-04 | 13 | 38 | 2 | CID005311256 | |
| Drug | mian | 2.09e-04 | 13 | 38 | 2 | CID000147614 | |
| Drug | Spiperone | 2.09e-04 | 13 | 38 | 2 | ctd:D013134 | |
| Drug | felbamate | 2.17e-04 | 70 | 38 | 3 | CID000003331 | |
| Drug | Nicorette | 2.24e-04 | 529 | 38 | 6 | CID000000942 | |
| Drug | picrotoxin | 2.31e-04 | 181 | 38 | 4 | CID000031304 | |
| Drug | phencyclidine | 2.31e-04 | 181 | 38 | 4 | CID000006468 | |
| Drug | EEDQ | 2.36e-04 | 72 | 38 | 3 | CID000027833 | |
| Drug | propiomazine | 2.44e-04 | 14 | 38 | 2 | CID000004940 | |
| Drug | Lisuride | 2.44e-04 | 14 | 38 | 2 | DB00589 | |
| Drug | Promazine | 2.44e-04 | 14 | 38 | 2 | DB00420 | |
| Drug | Pramipexole | 2.44e-04 | 14 | 38 | 2 | DB00413 | |
| Drug | azaperone | 2.44e-04 | 14 | 38 | 2 | CID000015443 | |
| Drug | Ropinirole | 2.44e-04 | 14 | 38 | 2 | DB00268 | |
| Drug | Paliperidone Palmitate | 2.44e-04 | 14 | 38 | 2 | ctd:D000068882 | |
| Drug | A68930 | 2.44e-04 | 14 | 38 | 2 | CID000122324 | |
| Drug | acemetacin | 2.44e-04 | 14 | 38 | 2 | CID000001981 | |
| Drug | Risperidone | 2.44e-04 | 14 | 38 | 2 | DB00734 | |
| Drug | Propiomazine | 2.44e-04 | 14 | 38 | 2 | DB00777 | |
| Drug | AC1L1DME | 2.67e-04 | 75 | 38 | 3 | CID000002414 | |
| Drug | Cabergoline | 2.81e-04 | 15 | 38 | 2 | DB00248 | |
| Drug | thiethylperazine | 2.81e-04 | 15 | 38 | 2 | CID000005440 | |
| Drug | elymoclavin | 2.81e-04 | 15 | 38 | 2 | CID000011051 | |
| Drug | PAK-104P | 2.81e-04 | 15 | 38 | 2 | CID000131368 | |
| Drug | Apomorphine | 2.81e-04 | 15 | 38 | 2 | DB00714 | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A | 3.01e-04 | 194 | 38 | 4 | 2034_UP | |
| Drug | LEO275 | 3.11e-04 | 79 | 38 | 3 | CID000018140 | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1821_UP | |
| Drug | AC1L4BIC | 3.21e-04 | 16 | 38 | 2 | CID000153998 | |
| Drug | decahydroisoquinoline | 3.21e-04 | 16 | 38 | 2 | CID000097812 | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3908_UP | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; HL60; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 6134_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 3561_UP | |
| Drug | AC1L1JSL | 3.35e-04 | 81 | 38 | 3 | CID000005188 | |
| Drug | Q740 | 3.59e-04 | 83 | 38 | 3 | CID000005203 | |
| Drug | Paliperidone | 3.63e-04 | 17 | 38 | 2 | DB01267 | |
| Drug | 3HPG | 3.63e-04 | 17 | 38 | 2 | CID000001217 | |
| Drug | PGW5 compound | 3.63e-04 | 17 | 38 | 2 | ctd:C000593032 | |
| Drug | Pergolide | 3.63e-04 | 17 | 38 | 2 | DB01186 | |
| Drug | D-N-Q | 3.72e-04 | 84 | 38 | 3 | CID000003140 | |
| Drug | AC1L1BXF | 3.85e-04 | 85 | 38 | 3 | CID000001650 | |
| Drug | spirodecanone | 4.08e-04 | 18 | 38 | 2 | CID000070556 | |
| Drug | Bromocriptine | 4.08e-04 | 18 | 38 | 2 | DB01200 | |
| Drug | acromelic acid A | 4.08e-04 | 18 | 38 | 2 | CID000108086 | |
| Drug | sulfinpyrazone | 4.13e-04 | 87 | 38 | 3 | CID000005342 | |
| Drug | amisulpride | 4.56e-04 | 19 | 38 | 2 | CID000002159 | |
| Drug | Methotrimeprazine | 4.56e-04 | 19 | 38 | 2 | DB01403 | |
| Drug | trifluperidol | 4.56e-04 | 19 | 38 | 2 | CID000005567 | |
| Drug | Apa-sg | 4.56e-04 | 19 | 38 | 2 | CID000126348 | |
| Drug | butyrophenone | 4.56e-04 | 19 | 38 | 2 | CID000010315 | |
| Drug | RP 62203 | 4.56e-04 | 19 | 38 | 2 | CID000060785 | |
| Drug | LY382884 | 4.56e-04 | 19 | 38 | 2 | CID000656723 | |
| Drug | HA1 100 | 4.56e-04 | 90 | 38 | 3 | CID003064778 | |
| Drug | aurintricarboxylic acid | 4.71e-04 | 91 | 38 | 3 | CID000002259 | |
| Drug | bromperidol | 5.06e-04 | 20 | 38 | 2 | CID000002448 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 5.06e-04 | 20 | 38 | 2 | CID000001297 | |
| Drug | O746 | 5.06e-04 | 20 | 38 | 2 | CID006327063 | |
| Drug | SCH 39166 | 5.06e-04 | 20 | 38 | 2 | CID000107930 | |
| Drug | cyproheptadine | 5.51e-04 | 96 | 38 | 3 | CID000002913 | |
| Drug | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 5.51e-04 | 96 | 38 | 3 | ctd:C080955 | |
| Drug | perlapine | 5.58e-04 | 21 | 38 | 2 | CID000016106 | |
| Drug | 2-butenedioate | 6.10e-04 | 234 | 38 | 4 | CID000000723 | |
| Drug | VX-710 | 6.13e-04 | 22 | 38 | 2 | CID000406509 | |
| Drug | setoperone | 6.13e-04 | 22 | 38 | 2 | CID000068604 | |
| Disease | Schizophrenia | 8.96e-06 | 883 | 36 | 8 | C0036341 | |
| Disease | Seasonal Affective Disorder | 1.72e-04 | 16 | 36 | 2 | C0085159 | |
| Disease | Bipolar Disorder | 2.70e-04 | 477 | 36 | 5 | C0005586 | |
| Disease | Colorectal Neoplasms | 3.53e-04 | 277 | 36 | 4 | C0009404 | |
| Disease | unipolar depression, bipolar disorder | 9.11e-04 | 156 | 36 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | Disease Exacerbation | 1.07e-03 | 165 | 36 | 3 | C0235874 | |
| Disease | Mood Disorders | 1.13e-03 | 168 | 36 | 3 | C0525045 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MWLSPSLLLLILPGY | 1 | Q6UXZ3 | |
| LLLLYGWAVIPMMYP | 1766 | P78363 | |
| LCLLLSLYGPWMPSS | 16 | Q14833 | |
| LLLLYGWSITPLMYP | 1741 | O95477 | |
| SMLTILYGYRWPLPS | 131 | P28223 | |
| PLGMPRLWTGYSLLY | 1481 | P53420 | |
| LLLSLFGYATLPWMY | 4541 | Q86UQ4 | |
| WYTYMLVPAALTGLL | 196 | A1A5B4 | |
| LLLLLYGWSITPLMY | 1621 | Q8IZY2 | |
| WLLLLLPPLSIMYYH | 1066 | Q5T3U5 | |
| LTLLWSPPDHMYLYQ | 666 | Q14667 | |
| WLPSLGLPQYRSYFM | 961 | O75145 | |
| VLLWEIFSLGYMPYP | 711 | P29376 | |
| LMLGCALPIYNKYWP | 21 | O95214 | |
| WLPSLGLPQYRSYFM | 971 | Q13136 | |
| WVLLSYYLGLLPFIP | 206 | Q7L5L3 | |
| SLWAPLGYLPLAMAL | 636 | Q96KJ4 | |
| FGLLPGLMLYATLWL | 291 | P23219 | |
| FFLPCPLMLLLYWAT | 201 | P21917 | |
| ALALLMYLPVLLWQY | 116 | Q96QZ0 | |
| LTGLPMYVKSLYWAL | 251 | A4D1S0 | |
| LWEMLAYVLLPLLYL | 176 | Q5UAW9 | |
| PDIWMYILLAYLGVS | 561 | Q13002 | |
| LSPDIWMYVLLAYLG | 561 | Q13003 | |
| LYPMYWQHIYIPVLP | 236 | Q6P3S1 | |
| TWYLLMPPALNPLVY | 296 | Q8NGH7 | |
| VMELPEGWYLPSYLT | 31 | Q9NQ40 | |
| PMYLWVLGPIYLLFI | 41 | O95255 | |
| PISMVLLTYGRWQYP | 216 | Q9BX95 | |
| LLPIMWQLYPDGRYR | 71 | P56279 | |
| TFSLIMLPEYLWGLP | 206 | Q8TDI8 | |
| MLPEYLWGLPYGSLP | 211 | Q8TDI8 | |
| MTLPSIGIPLLLWYS | 156 | P43308 | |
| WMGLFYCPLLPLLNS | 486 | Q8IU68 | |
| ALRPLPLDWMYLVYT | 106 | P38435 | |
| RMLGCTYLYPWILPK | 951 | Q6ZVD8 | |
| PMWYLKYLNIYVGLP | 71 | Q9NW08 | |
| INLIYIYPMIIHLWP | 616 | Q5TAH2 | |
| YTPLLGWLLTPNIYL | 76 | Q9H3S5 | |
| LPPWMYGLRNLEELY | 506 | Q8TDW0 |